New
HealthMore in Health→
Experimental Ebola PEP Offers Early Human Signal
Key Takeaways
- Nature Medicine published a case series on MBP134 used as post-exposure prophylaxis after Bundibugyo ebolavirus exposure.
- Five people from a single family cluster received the investigational antibody cocktail 5 to 6 days after exposure.
- The report says administration was well tolerated, with no treatment-related adverse events reported in the provided text.
DE
DT Editorial Team··via nature.com
